A Randomized Open Controlled Clinical Trial Comparing the Mean Healing Time With Collatamp Versus Directed Healing in Digestive Stoma Closures

NCT ID: NCT06980610

Last Updated: 2025-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-15

Study Completion Date

2027-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The process of directed healing is a slow one, not without any constraints for patients. In contact with the intestinal flora during the stoma time, the tissues harboring digestive bacteria do not allow direct skin closure without the risk of complications during the restoration of digestive continuity after having to perform an ileal or colonic stoma. Collatamp interposition would allow direct wound closure without additional complications. Various studies have compared directed healing and direct skin closure during stoma closure/restoration of continuity. Overall, directed healing reduces the risk of infection, abscesses, and surgical time, but results in greater constraints for the patient, i.e., longer healing time, more pain, and a poorer cosmetic result compared to direct skin closure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery, Colorectal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Interventional research with minimal risks and constraints, not involving a product mentioned in Article L. 5311-1 of the CSP
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COLLATAMP

The strategy under research is the surgical technique with Collatamp interposition between the musculoaponeurotic plane and the cutaneous plane during stoma closures.

Group Type EXPERIMENTAL

digestive stoma closures

Intervention Type PROCEDURE

Both surgical techniques (Collatamp interposition and directed healing) are routinely used in the CVMC and Digestive Cancer Surgery departments for stoma closure or restoration of digestive continuity. The choice of technique is at the surgeon\'s discretion.

Specific procedures related to the research:

Procedures that differ from standard management are randomization and patient completion of a questionnaire.

directed healing

The strategy used as a reference is the surgical technique of directed healing, with the use of an Algosteril wick.

Group Type ACTIVE_COMPARATOR

digestive stoma closures

Intervention Type PROCEDURE

Both surgical techniques (Collatamp interposition and directed healing) are routinely used in the CVMC and Digestive Cancer Surgery departments for stoma closure or restoration of digestive continuity. The choice of technique is at the surgeon\'s discretion.

Specific procedures related to the research:

Procedures that differ from standard management are randomization and patient completion of a questionnaire.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

digestive stoma closures

Both surgical techniques (Collatamp interposition and directed healing) are routinely used in the CVMC and Digestive Cancer Surgery departments for stoma closure or restoration of digestive continuity. The choice of technique is at the surgeon\'s discretion.

Specific procedures related to the research:

Procedures that differ from standard management are randomization and patient completion of a questionnaire.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person having received full information on the organization of the research and having signed their informed consent
* Patients aged 18 and over
* Patients requiring ileostomy or colostomy closure, or restoration of digestive continuity
* Person affiliated with a social security scheme or beneficiary of such a scheme

Exclusion Criteria

* Patient suffering from an immune deficiency (which would alter the healing process)
* Patient unable to complete the questionnaire
* Patient with a known intolerance, hypersensitivity, or allergy to aminoglycosides or bovine collagen
* Patient suffering from myasthenia gravis
* Woman of childbearing age without effective contraception
* Person referred to in Articles L. 1121-5, L. 1121-7, and L. 1121-8 of the French Public Health Code
* Pregnant woman, woman in labor, or breastfeeding mother
* Minor (non-emancipated)
* Adult subject to a legal protection measure (guardianship, curatorship, or legal protection)
* Adult unable to express consent . Person deprived of liberty by a judicial or administrative decision, person receiving psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Matthias MHM Hoeffel-Morgenthaler

Role: CONTACT

+33770058922

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A02240-47

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Suture Closure Trial
NCT05261425 ACTIVE_NOT_RECRUITING NA